Parenteral Drugs (India) Ltd.
| BSE: 524689 | Sector: Health care |
| NSE: PDPL | ISIN Code: INE904D01019 |
| BSE 00:00 | 09 Mar | Parenteral Drugs (India) Ltd |
| NSE 05:30 | 01 Jan | Parenteral Drugs (India) Ltd |
| OPEN | 2.50 |
| PREVIOUS CLOSE | 2.50 |
| VOLUME | 2000 |
| 52-Week high | 3.99 |
| 52-Week low | 2.34 |
| P/E | |
| Mkt Cap.(Rs cr) | 7 |
| Buy Price | 2.50 |
| Buy Qty | 2000.00 |
| Sell Price | 2.70 |
| Sell Qty | 2000.00 |
Parenteral Drugs (India) Ltd. (PDPL) - Announcements
-
Parenteral Drugs (India) Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
30/07/2020 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Compliances-Reg.24(A)-Annual Secretarial Compliance
29/07/2020 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Results- Financial Results For Mar 31 2020
29/07/2020 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Outcome Of Board Meeting Held On 29Th July 2020
29/07/2020 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
24/07/2020 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
23/07/2020 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Board Meeting Intimation for Consideration Of The Audited Financial Results (Both Standalone And Con
22/07/2020 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Shareholding for the Period Ended June 30 2020
21/07/2020 | bse
-
Parenteral Drugs (India) Ltd Statement Of Investor Complaints For The Quarter Ended June 2020
21/07/2020 | bse
-
Parenteral Drugs (India) Ltd Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015-Updates
06/07/2020 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Format of Initial Disclosure to be made by an entity identified as a Large Corporate
30/06/2020 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Compliances- Certificate Under Regulation 40 (10) Of SEBI (LODR) Regulations 2015
28/05/2020 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
26/05/2020 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Compliances-Compliance Certificate For The Period Ended March 2020
26/05/2020 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Compliances-Compliance Certificate For The Period Ended March 2020
26/05/2020 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Shareholding for the Period Ended March 31 2020
16/05/2020 | bse
-
Parenteral Drugs (India) Ltd Statement Of Investor Complaints For The Quarter Ended March 2020
15/05/2020 | bse
-
Parenteral Drugs (India) Ltd Announcement Under Regulation 30 (LODR) Updates- (OTS)
27/04/2020 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Announcemet Under Regulation 30 (LODR)- Updates
25/04/2020 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
13/02/2020 | bse |
Downlaod PDF
Quick Links for Parenteral Drugs (India):
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
